By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


MediGene AG 

Lochhamer Str. 11

Martinsried    82152   Germany
Phone: 49-89-85 65 29-00 Fax: 49-89-85 65 29-20



Company News
MediGene AG (MDGEF.PK): Veregen® Marketing Authorization Process Initiated For Eight Additional European Countries 9/30/2014 9:06:32 AM
MediGene AG (MDGEF.PK) To Present At PIVAC Conference Rome 9/25/2014 10:23:13 AM
MediGene AG (MDGEF.PK) To Present At Baader Investment Conference Munich 9/24/2014 8:46:56 AM
MediGene AG (MDGEF.PK): New Research Collaborations And Additional Grant For Immunotherapy TABs 9/22/2014 8:55:14 AM
MediGene AG (MDGEF.PK) Significantly Improves Financial Results For The First Six Months Of 2014 8/7/2014 8:50:54 AM
MediGene AG (MDGEF.PK): Trianta Announces Extension Of Research Funding In The Transregional Collaborative Research Centre Of The German Research Foundation (DFG) For Adoptive T Cell Therapy 7/22/2014 9:11:24 AM
MediGene AG (MDGEF.PK)'s Drug Veregen® Launched In Canada 7/17/2014 9:02:41 AM
MediGene AG (MDGEF.PK): m4 Award Project On The Development Of Optimized DC Vaccine Formulation Successfully Completed 6/25/2014 8:50:55 AM
MediGene AG (MDGEF.PK) Announces Market Launch Of Veregen®: In Belgium, Denmark And Finland 6/12/2014 7:55:02 AM
MediGene AG (MDGEF.PK): Trianta Receives BMBF (Federal Ministry Of Education And Research) Grant For Tabs Immunotherapy As Part Of The "M4 Leading-Edge Cluster Initiative" 6/6/2014 10:57:07 AM